Related references
Note: Only part of the references are listed.Surprisingly high stability of the Aβ oligomer eliminating all-D-enantiomeric peptide D3 in media simulating the route of orally administered drugs
Anne Elfgen et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Large-Scale Oral Treatment Study with the Four Most Promising D3-Derivatives for the Treatment of Alzheimer's Disease
Janine Kutzsche et al.
MOLECULES (2017)
The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathology
Thomas van Groen et al.
SCIENTIFIC REPORTS (2017)
Suppression of Oligomer Formation and Formation of Non-Toxic Fibrils upon Addition of Mirror-Image Aβ42 to the Natural L-Enantiomer
Subrata Dutta et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Pharmacokinetic Properties of a Novel D-Peptide Developed to be Therapeutically Active Against Toxic β-Amyloid Oligomers
Leonie H. E. Leithold et al.
PHARMACEUTICAL RESEARCH (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Toward Oral Delivery of Biopharmaceuticals: An Assessment of the Gastrointestinal Stability of 17 Peptide Drugs
Jie Wang et al.
MOLECULAR PHARMACEUTICS (2015)
Alzheimer disease: Epidemiology, diagnostic criteria, risk factors and biomarkers
Christiane Reitz et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Novel human D-amino acid oxidase inhibitors stabilize an active-site id-open conformation
Ryan T. Terry-Lorenzo et al.
BIOSCIENCE REPORTS (2014)
D-Amino acids in the brain and mutant rodents lacking D-amino-acid oxidase activity
Masahiro Yamanaka et al.
AMINO ACIDS (2012)
Structure-function relationships in human d-amino acid oxidase
Silvia Sacchi et al.
AMINO ACIDS (2012)
Peptides for Therapy and Diagnosis of Alzheimer's Disease
Susanne Aileen Funke et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
A Survey of Peptides with Effective Therapeutic Potential in Alzheimer's Disease Rodent Models or in Human Clinical Studies
N. Sun et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2012)
The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
Iryna Benilova et al.
NATURE NEUROSCIENCE (2012)
D-Amino acid metabolism in mammals: Biosynthesis, degradation and analytical aspects of the metabolic study
Hiroko Ohide et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2011)
Brain Oligomeric β-Amyloid but Not Total Amyloid Plaque Burden Correlates With Neuronal Loss and Astrocyte Inflammatory Response in Amyloid Precursor Protein/Tau Transgenic Mice
Bibiana DaRocha-Souto et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Eric Karran et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
The conduct of drug metabolism studies considered good practice (II):: In vitro experiments
Lee Jia et al.
CURRENT DRUG METABOLISM (2007)
Characterization of human D-amino acid oxidase
G Molla et al.
FEBS LETTERS (2006)
Strategies to improve plasma half life time of peptide and protein drugs
M. Werle et al.
AMINO ACIDS (2006)
Partial D-amino acid substitution:: Improved enzymatic stability and preserved Ab recognition of a MUC2 epitope peptide
R Tugyi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Identification of formaldehyde-induced modifications in proteins - Reactions with model peptides
B Metz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
In vitro uptake and stability study of pVEC and its all-D analog
A Elmquist et al.
BIOLOGICAL CHEMISTRY (2003)
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
DM Walsh et al.
NATURE (2002)
Share Paper
